Newsmeme!
Discover News you didn't know existed
RSNA -- IBM unveiled a powerful new combination of advanced imaging and information archiving technologies that provides healthcare and research organizations with complete and timely access to critical imaging and diagnostic information at the point of care -- regardless of the source, age or location of the information. IBM's new Healthcare Image and Information Grid framework is built on ...
NEW YORK----IndexIQ, a leading developer of index-based alternative investment solutions, has introduced three new index-based separately managed account products, it was announced today.
NEW YORK----The Credit Suisse Inverse Long/Short Equity Replication Index was up 1.27% net in November, according to Jordan Drachman, Head of Research for Alternative Beta Strategies at Credit Suisse.
FalconStor Software, Inc. (NASDAQ: FALC), the provider of TOTALLY Open™ data protection solutions, today announced a new file-interface data deduplication system along with enhancements and support for high-performance connectivity to its widely deployed Virtual Tape Library (VTL) software.
In future, Norddeutsche Landesbank Girozentrale (NORD/LB), one of the largest German financial institutions, will benefit fully from the Margin ...
StoneFly, Inc., a leading supplier of integrated IP storage area network systems and a wholly-owned subsidiary of Dynamic Network Factory, Inc., today introduced OptiSAN(TM)-HD, a new IP SAN that blends high-performance operation with straightforward, economical IP SAN technology to optimize enterprise storage networking for the most demanding IT environments.
Like tuning a violin to produce strong, elegant notes, researchers at The Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted to keep the cells in superb infection- and disease-fighting condition.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
Research and Markets ( http://www.researchandmarkets.com/research/af5912/neuronal_stem_pr ) has announced the addition of the "Neuronal Stem & Progenitor Cells" report to their offering.
DUBLIN, Ireland----Research and Markets has announced the addition of the "Neuronal Stem & Progenitor Cells" report to their offering.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |